Claire E. Fletcher

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Fat's all, folks: culturing and manipulating peri-prostatic adipocytes to probe impacts on prostate cancer biology.

Fat's all, folks: culturing and manipulating peri-prostatic adipocytes to probe impacts on prostate cancer biology.

Journal: The Journal of endocrinology

Published: July 08, 2025

Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growth.

Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growth.

Journal: Frontiers in oncology

Published: May 29, 2024

PLK1 Regulates MicroRNA Biogenesis through Drosha Phosphorylation.

PLK1 Regulates MicroRNA Biogenesis through Drosha Phosphorylation.

Journal: International journal of molecular sciences

Published: August 21, 2023

Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer.

Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer.

Journal: The Journal of endocrinology

Published: December 19, 2022

Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?

Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?

Journal: Cancers

Published: December 15, 2021

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.

Journal: Molecular cancer

Published: October 20, 2021

Coordinated AR and microRNA regulation in prostate cancer.

Coordinated AR and microRNA regulation in prostate cancer.

Journal: Asian journal of urology

Published: August 11, 2019

The Role of Splicing Regulators in the Emergence of Treatment-induced Neuroendocrine Prostate Cancer: The Next Generation of Drug Targets?

The Role of Splicing Regulators in the Emergence of Treatment-induced Neuroendocrine Prostate Cancer: The Next Generation of Drug Targets?

Journal: European urology

Published: April 03, 2019

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.

Journal: Oncogene

Published: May 03, 2018

AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease.

AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease.

Journal: Human molecular genetics

Published: March 09, 2018

AR-v7 liquid biopsy for treatment stratification in prostate cancer: how close are we?

AR-v7 liquid biopsy for treatment stratification in prostate cancer: how close are we?

Journal: Current opinion in urology

Published: June 08, 2017

Recurrence of dyskinesia as a side-effect of mirabegron in a patient with Parkinson's disease on DBS (GPi).

Recurrence of dyskinesia as a side-effect of mirabegron in a patient with Parkinson's disease on DBS (GPi).

Journal: Parkinsonism & related disorders

Published: January 26, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026